Up to 150 new jobs have been announced by the multinational pharmaceutical company GlaxoSmithKline at its plant at Currabinny in County Cork. IDA Ireland is supporting the €250m investment.
Earlier this month the company was given the go-ahead by the US Food and Drug Administration to begin manufacturing a pioneering drug for the treatment of breast cancer. The plant in Cork - with the support of the IDA - has been successful in its bid to produce the drug.
Breast cancer is the most frequently-diagnosed cancer in women. There are more than one million new cases worldwide every year. Tykerb is the new drug for the treatment of breast cancer developed by GSK. It is the first, once-daily oral treatment for women with advanced breast cancer.
The 150 jobs the project is expected to create will further enhance GlaxoSmithKline's relationship with Ireland, bringing to 750 the number employed at the Currabinny plant, and 1,750 nationally. GSK has four sites in Cork, Dublin and Dungarvan.
